Tech Company Financing Transactions

Nirogy Therapeutics Funding Round

Nirogy Therapeutics secured a $16.5 million Series A venture capital round on 1/27/2021. Investors included Sante Ventures, Sporos Bioventures and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

27 Strathmore Rd.
Natick, MA 01760
USA

Phone

Undisclosed

Website

www.nirogytx.com

Email Address

[email protected]

Overview

Nirogy therapeutics, originally named as Nirogyone Therapeutics, is based in the biotech hub of Boston-Cambridge, MA. Founded in 2014, launched in 2019 with seed funding, Nirogy was born as a culmination of extensive search for new molecular targets in cellular metabolism.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Vincent Sandanayaka

        

Vice President

Jaime Escobedo

        

Browse more venture capital transactions:

Prev: 1/27/2021: Albert venture capital transaction
Next: 1/27/2021: Joshu venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary